Compare Citius Pharmaceuticals Inc (CTXR) vs Quantumscape Corp (QS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Quantumscape Corp — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Quantumscape Corp trades at $6.38 (market cap $3.90B). The key difference: Quantumscape Corp is far larger — about 194.9× Citius Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| CTXR | QS | |
|---|---|---|
Market Cap | $20.01M | $3.90B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.82 | $18.44 |
52-Week Low | $0.48 | $4.89 |
Enterprise Value | $16.23M | $3.11B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Quantumscape Corp
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →
